6,6'-dicorynomycolyl trehalose has been researched along with B16 Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Himeno, S; Imagawa, H; Inoue, M; Nagahama, M; Nakano, M; Nishizawa, M; Oda, M; Sakurai, J; Setsu, K; Shibutani, M; Watanabe, N; Yabiku, K; Yamamoto, H | 1 |
| McGee, JM; Patten, MR; Price, JA; Snyder, D | 1 |
2 other study(ies) available for 6,6'-dicorynomycolyl trehalose and B16 Melanoma
| Article | Year |
|---|---|
Development of vizantin, a safe immunostimulant, based on the structure-activity relationship of trehalose-6,6'-dicorynomycolate.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Cell Line, Tumor; Cord Factors; Glycolipids; Humans; In Vitro Techniques; Lung Neoplasms; Macrophages; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Phagocytosis; Stereoisomerism; Structure-Activity Relationship; Trehalose; Xenograft Model Antitumor Assays | 2013 |
Effects of the adjuvant MPL + TDM on tumor challenge in the B16 mouse melanoma model.
Topics: Adjuvants, Immunologic; Animals; Cord Factors; Lipid A; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Tumor Cells, Cultured | 1996 |